Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
259 participants
OBSERVATIONAL
2019-03-04
2020-08-08
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Response Assessment in SB CD
NCT03646708
Helmsley 3.0: Abbreviated MRE
NCT06533228
Significance and Outcome of Magnetic Resonance Enterography Revealing Sacroiliitis in Crohn's Disease: A Pilot Study
NCT05203926
Evaluation of a New Oral Contrast Agent for MR Enterography in the Assessment of Crohn Disease in the Small Bowel
NCT00587210
Combined [18F]-FDG PET-MRI in Diagnostics and Surveillance of Small Bowel Crohn's Disease
NCT06796959
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This study aims to: (i) determine the validity, sensitivity and specificity of MRE as a screening tool for axSpA in CD patients using dedicated axial MRI scans with clinical assessment as the gold standard; (ii) devise an algorithm of clinical indices that can be used as a screening tool for axSpA in CD cases.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ProSpA-CD Screen Phase: MRE review for axSpA
Review of MRE scan for evidence of axSpA in Crohn's disease patients
MRE review for evidence of axSpA in SIJs
Screening for evidence of axSpA on the MRE scan of patients with Crohn's disease
ProSpA-CD Assess Phase (cases): Clinical assessment and dedicated MRI of the spine and pelvis
Clinical assessment and dedicated MRI of the spine and pelvis to assess for evidence of axSpA for participants with abnormalities identified in the sacroiliac joints (SIJs) on MRE (cases).
Clinical assessment and dedicated MRI of the spine and pelvis
Clinical assessment and dedicated MRI of the spine and pelvis to assess for evidence of axSpA
ProSpA-CD Assess Phase (controls): Clinical assessment and dedicated MRI of the spine and pelvis
Clinical assessment and dedicated MRI of the spine and pelvis to assess for evidence of axSpA for participants with normal SIJs (controls) on MRE.
Clinical assessment and dedicated MRI of the spine and pelvis
Clinical assessment and dedicated MRI of the spine and pelvis to assess for evidence of axSpA
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MRE review for evidence of axSpA in SIJs
Screening for evidence of axSpA on the MRE scan of patients with Crohn's disease
Clinical assessment and dedicated MRI of the spine and pelvis
Clinical assessment and dedicated MRI of the spine and pelvis to assess for evidence of axSpA
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Male and female subjects aged 18 years or above.
3. Diagnosed by the gastroenterology team with Crohn's disease.
4. MRE imaging since 2015 for their Crohn's disease.
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Merck Sharp & Dohme LLC
INDUSTRY
Cambridge University Hospitals NHS Foundation Trust
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jobie Evans
Dr Jobie Evans (MD Student)
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Deepak R Jadon, MBBCh PhD
Role: PRINCIPAL_INVESTIGATOR
CUH NHSFT
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rheumatology Research Unit
Cambridge, Cambridgeshire, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
A094864
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.